Europe Drug Coated Stent Market was valued at USD 1.67 Billion in 2022 and is projected to reach USD 2.70 Billion by 2030, growing at a CAGR of 7.8% from 2024 to 2030.
The Europe Drug Coated Stent Market is witnessing significant growth as it plays a critical role in the treatment of coronary artery diseases. These stents, which are coated with a drug to prevent the re-narrowing of arteries after they’ve been opened, have become a cornerstone in modern cardiovascular procedures. The market is evolving with increasing demand for effective and long-lasting solutions to manage cardiovascular conditions, which are prevalent in a large portion of Europe’s aging population.
The demand for drug-coated stents is largely driven by advancements in medical technology and growing awareness about heart diseases. With chronic conditions like atherosclerosis becoming more common, drug-coated stents offer a promising solution by preventing the need for repeat procedures, thereby improving the overall patient quality of life. This rise in demand has been spurred by technological innovations, including bioresorbable stents, which are dissolving stents that provide temporary support and then disappear, reducing the long-term complications associated with traditional stents.
Industries in Europe, particularly the healthcare sector, are continuously seeking improvements in drug-coated stent designs and materials. This has led to a more diverse range of products entering the market, such as those with bioengineered coatings designed to minimize the risk of restenosis (re-narrowing of the artery). Additionally, pharmaceutical companies are working on developing stents with drugs that target specific cellular mechanisms to further reduce complications.
One of the key drivers in the European market is the increasing collaboration between stent manufacturers and pharmaceutical companies to enhance the efficacy of drug-coated stents. As the healthcare industry embraces new and innovative treatments, drug-coated stents continue to be an essential tool in reducing healthcare costs and improving patient outcomes. The demand from industries, particularly hospitals and cardiovascular specialists, remains high, with continuous advancements expected in the next decade to improve stent performance and patient safety.
Given the increasing requirement from healthcare industries, the Europe Drug Coated Stent Market is set to experience substantial growth. Companies focusing on research and development are critical in meeting the evolving needs of the medical community, ensuring the continued success and relevance of these devices in treating heart diseases.
Get an In-Depth Research Analysis of the Europe Drug Coated Stent Market Size And Forecast [2025-2032]
Â
Biosensors International
Abbott Laboratories
Advantec Vascular
B. Braun
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Drug Coated Stent Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Drug Coated Stent Market
Balloon-Expandable Drug-Coated Stents
Self-Expanding Drug-Coated Stents
Polymer-Coated Stents
Non-Polymer-Coated Stents
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
Sirolimus-Eluting Stents
Paclitaxel-Eluting Stents
Zotarolimus-Eluting Stents
Coronary Artery Disease
Peripheral Artery Disease
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Drug Coated Stent Market Research Analysis
1. Introduction of the Europe Drug Coated Stent Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Drug Coated Stent Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Drug Coated Stent Market, By Type
6. Europe Drug Coated Stent Market, By Application
7. Europe Drug Coated Stent Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Drug Coated Stent Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/